Overview

Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
To assess the ocular and systemic safety and tolerability of a single intravitreal injection of VEGF Trap in patients with diabetic macular edema.
Phase:
Phase 1
Details
Lead Sponsor:
Regeneron Pharmaceuticals
Treatments:
Aflibercept